No profile data available.
Firefly Neuroscience, Inc. (AIFF) is a healthcare company in the targeted healthcare equipment industry, based in Kenmore, United States, with about 17 full-time employees.
It reported revenue of $1.14 million for fiscal year 2025, up 957.4% from fiscal year 2024, and net income of -$24.53 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $485,000, up 1027.9% from a year before. Its market capitalization was $18.67 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America.
Firefly Neuroscience reported $1.14 million in revenue for fiscal year 2025, up 957.4% from $108,000 in fiscal year 2024. In Q1 2026 revenue was $485,000.
$18.67 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Abvc BioPharma, Inc. (ABVC), InspireMD, Inc. (NSPR), SeaStar Medical Holding Corporation (ICU), Nexalin Technology, Inc. (NXL).